EHR Scheduling Aids Operating Room Scheduling Accuracy
By Lori Solomon HealthDay Reporter
WEDNESDAY, March 27, 2024 -- The use of electronic health record (EHR) systems for predicting operation times improves operating room (OR) scheduling accuracy, according to a study published in the March/April issue of the Journal of Healthcare Management.
Mohamed Elsaqa, M.D., from the Baylor Scott & White Medical Center in Temple, Texas, and colleagues assessed the use of the EHR for OR scheduling and the impact of surgeon manipulations on OR time accuracy. OR time accuracy in the five months before the trial (4,243 operations) was compared to that in the trial period (4,578 operations).
The researchers found that the percentage of manipulation dropped from 19.8 to 7.6 percent, while scheduling accuracy rose from 41.7 to 47.9 percent. There was a significant reduction of underscheduling percentage (38.7 versus 31.7 percent) with no significant difference in the percentage of overscheduled cases (15 versus 17 percent). During the trial period, inaccurate OR hours were reduced by 18 percent (2,383 versus 1,954 hours).
"Reducing the manipulation of OR scheduling can improve scheduling accuracy, thus maximizing time usage, avoiding delays, and enhancing patient satisfaction," the authors write. "Further studies of longer duration with generalization to all surgical specialties are required to fully validate the benefits."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
![](/img/logo/vendor/healthday-logo.png)
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.